Evidence map›Paper›PMID 27182258›Full record

ArticlePakistan journal of medical sciences

Application of multiplex PCR for Rapid and sensitive detection of human papillomaviruses in cervical cancer.

Fateme Zandnia, Abbas Doosti, Abbas Mokhtari-Farsani, Mohammad Taghi Kardi, Abolfazl Movafagh

Abstract read
In one paragraph

Article in Pakistan journal of medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fateme ZandniaFateme Zandnia, Biotechnology Research Center, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran.
Abbas DoostiAbbas Doosti, Biotechnology Research Center, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran.
Abbas Mokhtari-FarsaniAbbas Mokhtari-Farsani, Young Researchers and Elite Club, Biotechnology Research Center, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran.
Mohammad Taghi KardiMohammad Taghi Kardi, Department of Biology, University of Isfahan, Isfahan, Iran.
Abolfazl MovafaghAbolfazl Movafagh, Department of Medical Genetics, Pediatric Neurology Research Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesReffering to an increase in cervical cancer in the recent years, rapid, sensitive and economical detection of human papillomaviruses (HPVs) as causative agents of cervical cancer is important. The traditional methods for the detection of HPVs in cervical cancer, such as pap smear, suffer from limitation and PCR has a potential to overcome the limitaitons. The purpose of present research work was to identify the five important strains of HPV (16, 18, 31, 33 and 45) simultaneously by Multiplex PCR application.

methodsStudy was done on 100 cervical lesions of women. DNA was extracted from specimens by a genomic DNA purification kit. A 5-plex PCR was developed for the simultaneous detection of major HPV. Five pair of new primers was designed for detection of HPV 16, 18, 31, 33 and 45 by Multiplex PCR.

resultsAmong the 100 evaluated samples, 82 were found positive to HPVs. In the meantime the highest rate of infection was for HPV 16. Also 30 of HPV positive samples had infections with two or more HPV types.

conclusionMultiplex PCR assay used in present study can provide a rapid, sensitive and economical method for detection of viral infections and is applicable to small volumes of vaginal samples.

Indexed as

BiomarkerCervical cancerHuman papillomavirusMultiplex PCR

Identifiers

PMID27182258
PMCPMC4859041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.